SEC Form 4 · accession 0001209191-18-031546
AMICUS THERAPEUTICS, INC. · FOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Margaret G McGlynn
Director
Period of report
May 16, 2018
Accepted (ET)
May 18, 2018 · 6:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 16, 2018 | M | 10,000 | $3.32 | A | 25,814 | D | |
| Common Stock | May 16, 2018 | S | 10,000 | $16.00 | D | 15,814 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F2 | $3.32 | May 16, 2018 | M | 10,000 | D | — | Mar 16, 2020 | Common Stock | 10,000 | 20,000 | D |
Explanation of responses
- F1The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2018.
- F2All of the options were fully vested and exercisable as of May 16, 2018.